Medistim ASA (STO:MEDIO)

Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of SEK 4.47 billion. The enterprise value is 4.40 billion.

Market Cap	4.47B
Enterprise Value	4.40B

Important Dates

The last earnings date was Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	18.27M
Shares Outstanding	n/a
Shares Change (YoY)	-0.07%
Shares Change (QoQ)	-0.33%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.61M

Valuation Ratios

The trailing PE ratio is 36.29 and the forward PE ratio is 32.37.

PE Ratio	36.29
Forward PE	32.37
PS Ratio	7.58
PB Ratio	12.40
P/TBV Ratio	15.01
P/FCF Ratio	32.57
P/OCF Ratio	31.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.16, with an EV/FCF ratio of 32.06.

EV / Earnings	35.72
EV / Sales	7.45
EV / EBITDA	24.16
EV / EBIT	27.34
EV / FCF	32.06

Financial Position

The company has a current ratio of 3.14, with a Debt / Equity ratio of 0.06.

Current Ratio	3.14
Quick Ratio	1.73
Debt / Equity	0.06
Debt / EBITDA	0.11
Debt / FCF	0.15
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 34.19% and return on invested capital (ROIC) is 26.75%.

Return on Equity (ROE)	34.19%
Return on Assets (ROA)	21.13%
Return on Invested Capital (ROIC)	26.75%
Return on Capital Employed (ROCE)	41.59%
Revenue Per Employee	3.83M
Profits Per Employee	800,471
Employee Count	154
Asset Turnover	1.24
Inventory Turnover	0.71

Taxes

In the past 12 months, Medistim ASA has paid 38.39 million in taxes.

Income Tax	38.39M
Effective Tax Rate	23.75%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	199.37
200-Day Moving Average	n/a
Relative Strength Index (RSI)	63.76
Average Volume (20 Days)	328

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of SEK 590.40 million and earned 123.27 million in profits. Earnings per share was 6.74.

Revenue	590.40M
Gross Profit	476.71M
Operating Income	160.79M
Pretax Income	161.66M
Net Income	123.27M
EBITDA	173.70M
EBIT	160.79M
Earnings Per Share (EPS)	6.74

Balance Sheet

The company has 90.57 million in cash and 20.71 million in debt, giving a net cash position of 69.86 million.

Cash & Cash Equivalents	90.57M
Total Debt	20.71M
Net Cash	69.86M
Net Cash Per Share	n/a
Equity (Book Value)	360.78M
Book Value Per Share	19.74
Working Capital	248.47M

Cash Flow

In the last 12 months, operating cash flow was 143.06 million and capital expenditures -5.70 million, giving a free cash flow of 137.35 million.

Operating Cash Flow	143.06M
Capital Expenditures	-5.70M
Free Cash Flow	137.35M
FCF Per Share	n/a

Margins

Gross margin is 80.74%, with operating and profit margins of 27.23% and 20.88%.

Gross Margin	80.74%
Operating Margin	27.23%
Pretax Margin	27.38%
Profit Margin	20.88%
EBITDA Margin	29.42%
EBIT Margin	27.23%
FCF Margin	23.26%

Dividends & Yields

Medistim ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.07%
Shareholder Yield	n/a
Earnings Yield	2.76%
FCF Yield	3.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6